Recruiting Idiopathic Thrombocytopenic Purpura Studies in Los Angeles
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it ...
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP). After an up to 2 weeks screening period, el...
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
The purpose of the phase 1 part of this study is to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and sa...
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP...
About Idiopathic Thrombocytopenic Purpura Clinical Trials in Los Angeles
Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.
There are currently 4 idiopathic thrombocytopenic purpura clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 332 participants. Research is being sponsored by Takeda, argenx, Eli Lilly and Company and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Idiopathic Thrombocytopenic Purpura Clinical Trials in Los Angeles — FAQ
Are there idiopathic thrombocytopenic purpura clinical trials in Los Angeles?
Yes, there are 4 idiopathic thrombocytopenic purpura clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What idiopathic thrombocytopenic purpura treatments are being tested?
The 4 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.
Data updated March 2, 2026 from ClinicalTrials.gov